Benitec Biopharma (BNTC) Operating Income (2019 - 2025)
Benitec Biopharma (BNTC) reported Operating Income of -$13.4 million for Q4 2025, down 23.8% on a YoY basis from -$17.6 million in Q4 2024, and down 36.46% sequentially from -$9.8 million in Q3 2025.
Benitec Biopharma (BNTC) Operating Income (2019 - 2025) Analysis & Trends
Benitec Biopharma (BNTC) has 7 years of Operating Income data on file, last reported at -$13.4 million in Q4 2025.
- For the quarter ending Q4 2025, Operating Income fell 23.8% year-over-year to -$13.4 million; the trailing twelve-month figure through Dec 2025 stood at -$48.3 million (down 83.94% YoY), and the FY2025 full-year result was -$41.8 million, down 85.7% from the prior year.
- Operating Income fell to -$13.4 million in Q4 2025, from -$9.8 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of -$3.5 million in Q1 2022 to a low of -$15.3 million in Q1 2025.
- A 5-year average of -$6.6 million and a median of -$5.2 million in 2021 frame the typical range for Operating Income.
- Across the five-year window, Operating Income climbed 8.78% in 2022 and sank 270.32% in 2025, its largest moves.
- Tracing BNTC's Operating Income over 5 years: stood at -$4.8 million in 2021, then declined by 16.03% to -$5.6 million in 2022, then decreased by 23.48% to -$6.9 million in 2023, then plunged by 55.98% to -$10.8 million in 2024, then fell by 23.8% to -$13.4 million in 2025.
- Business Quant data shows BNTC's Operating Income at -$13.4 million in Q4 2025, -$9.8 million in Q3 2025, and -$9.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Benitec Biopharma | 46.45 Mn | 46.45 Mn | - | -13.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -13.38 Mn |
| Sep 30, 2025 | -9.80 Mn |
| Jun 30, 2025 | -9.83 Mn |
| Mar 31, 2025 | -15.34 Mn |
| Dec 31, 2024 | -10.81 Mn |
| Sep 30, 2024 | -5.79 Mn |
| Jun 30, 2024 | -5.55 Mn |
| Mar 31, 2024 | -4.14 Mn |
| Dec 31, 2023 | -6.93 Mn |
| Sep 30, 2023 | -5.87 Mn |
| Jun 30, 2023 | -4.55 Mn |
| Mar 31, 2023 | -4.34 Mn |
| Dec 31, 2022 | -5.61 Mn |
| Sep 30, 2022 | -4.58 Mn |
| Jun 30, 2022 | -4.74 Mn |
| Mar 31, 2022 | -3.46 Mn |
| Dec 31, 2021 | -4.84 Mn |
| Sep 30, 2021 | -4.82 Mn |
| Jun 30, 2021 | -3.86 Mn |
| Mar 31, 2021 | -3.79 Mn |